Mirabegron (Myrbetriq) Production Cost Reports

The report provides a detailed analysis essential for establishing a Mirabegron (Myrbetriq) manufacturing plant. It encompasses all critical aspects necessary for Mirabegron (Myrbetriq) production, including the cost of Mirabegron (Myrbetriq) production, Mirabegron (Myrbetriq) plant cost, Mirabegron (Myrbetriq) production costs, and the overall Mirabegron (Myrbetriq) manufacturing plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Mirabegron (Myrbetriq) production plant. These encompass manufacturing processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Mirabegron (Myrbetriq) is an aromatic amide having pharmacological effects and is widely used as a drug in the medical and pharmaceutical industries. It is extensively utilized as medication for the treatment of overactive bladder (OAB) that is associated with Increased micturition frequency and urgency incontinence. Moreover, it is also employed in the management and treatment of urinary urgency or frequent need to urinate and neurogenic detrusor overactivity (NDO).

The market for Mirabegron (Myrbetriq) is predominantly driven by its extensive usage as a beta-3 adrenergic agonist for the treatment of overactive bladder and prevention of involuntary urine leakage, which remarkably promotes its demand in the pharmaceutical industry. Additionally, its medical applications in treating urgency incontinence and neurogenic detrusor overactivity further contribute to its demand in the medical and pharmaceutical industries. Furthermore, several factors influence industrial Mirabegron procurement, such as the availability of raw materials, cost, and pricing, compliance with pharmaceutical regulations, quality standards, technological advancements, environmental considerations, sustainability practices, distribution (including trading and shipping), logistics, safety standards, etc.

Raw Material for Mirabegron (Myrbetriq) Production

According to the Mirabegron (Myrbetriq) manufacturing plant project report, the major raw materials for Mirabegron (Myrbetriq) production include 2-(2-aminothiazol-4-yl) acetic acid- Thionyl Chloride.

Manufacturing Process of Mirabegron (Myrbetriq)

The extensive Mirabegron (Myrbetriq) production cost report consists of the following industrial manufacturing process:

• Production via Chemical Synthesis: The formation of the starting material initiates this production process, 2-(2-aminothiazol-4-yl) acetic acid, which is further reacted with thionyl chloride to convert it into its acyl chloride form. Further, the obtained acyl chloride is then reacted with a tertiary amine (N-(2,6-dimethylphenyl)-2-(2-oxo-1-pyrrolidinyl)acetamide), followed by purification processes, such as recrystallization or chromatography to produce mirabegron as the desired product.

Mirabegron (Myrbetriq) is regarded as a monocarboxylic acid amide, having a molecular weight of 396.5 g/mol. The molecular formula of the compound is C21H24N4O2S. This drug is also known as Myrbetriq, Betanis, Betmiga, etc., and it belongs to the class of 1,3-thiazoles. The IUPAC name of the compound is 2-(2-amino-1,3-thiazol-4-yl)-N-[4-[2-[[(2R)-2-hydroxy-2-phenylethyl]amino]ethyl]phenyl]acetamide, and its solubility is 0.082mg/mL. Moreover, it is mainly prescribed as a medicine for the treatment of overactive bladder syndrome. The melting point of the compound is 144 degrees Celsius and it dissolves in organic solvents, such as ethanol, DMF, and DMSO. Additionally, its melting point is 138-140°C.